JM2 Capital’s Amgen AMGN Stock Holding History

JM2 Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$219K	Buy	+520	New	+$207K	0.15%	113

Other funds holding AMGN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

JM2 Capital's AMGN Position: Q3 2026 in Review

JM2 Capital opened a new position in Amgen (AMGN) in Q3 2026: 520 shares worth $219K. The stake represents 0.15% of the portfolio and ranks #113 among its holdings.

790 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

JM2 Capital held 520 shares of Amgen worth $219K as of Q3 2026.
Amgen was a new JM2 Capital position in Q3 2026.
Amgen made up 0.15% of JM2 Capital's portfolio in Q3 2026, its #113 holding.
790 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on JM2 Capital's 13F filing for Q3 2026, filed 14 Oct 2026.